IGC Pharma(IGC)
POTOMAC, MDPharmaceutical
Focus: IGC Pharma is a public-stage pharmaceutical company focused on cannabinoid-based therapies for Alzheimer's disease and neurology. The company operates at a micro-cap scale with minimal revenue and significant R&D investment.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About IGC Pharma
AI assessmentNot HiringNo open roles listed right now. Follow IGC Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from IGC Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$1M
FY2025
Pipeline & Clinical Trials
Help build intelligence for IGC Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.